These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18094188)

  • 1. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium.
    Sheahan T; Rockx B; Donaldson E; Sims A; Pickles R; Corti D; Baric R
    J Virol; 2008 Mar; 82(5):2274-85. PubMed ID: 18094188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.
    Sheahan T; Rockx B; Donaldson E; Corti D; Baric R
    J Virol; 2008 Sep; 82(17):8721-32. PubMed ID: 18579604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.
    Rockx B; Sheahan T; Donaldson E; Harkema J; Sims A; Heise M; Pickles R; Cameron M; Kelvin D; Baric R
    J Virol; 2007 Jul; 81(14):7410-23. PubMed ID: 17507479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus.
    Liu L; Fang Q; Deng F; Wang H; Yi CE; Ba L; Yu W; Lin RD; Li T; Hu Z; Ho DD; Zhang L; Chen Z
    J Virol; 2007 May; 81(9):4694-700. PubMed ID: 17314167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy.
    Qu XX; Hao P; Song XJ; Jiang SM; Liu YX; Wang PG; Rao X; Song HD; Wang SY; Zuo Y; Zheng AH; Luo M; Wang HL; Deng F; Wang HZ; Hu ZH; Ding MX; Zhao GP; Deng HK
    J Biol Chem; 2005 Aug; 280(33):29588-95. PubMed ID: 15980414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.
    Deming D; Sheahan T; Heise M; Yount B; Davis N; Sims A; Suthar M; Harkema J; Whitmore A; Pickles R; West A; Donaldson E; Curtis K; Johnston R; Baric R
    PLoS Med; 2006 Dec; 3(12):e525. PubMed ID: 17194199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
    Sims AC; Burkett SE; Yount B; Pickles RJ
    Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody.
    Ng OW; Keng CT; Leung CS; Peiris JS; Poon LL; Tan YJ
    PLoS One; 2014; 9(7):e102415. PubMed ID: 25019613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
    J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
    Li F
    J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.
    Kam YW; Okumura Y; Kido H; Ng LF; Bruzzone R; Altmeyer R
    PLoS One; 2009 Nov; 4(11):e7870. PubMed ID: 19924243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
    van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
    J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.
    Becker MM; Graham RL; Donaldson EF; Rockx B; Sims AC; Sheahan T; Pickles RJ; Corti D; Johnston RE; Baric RS; Denison MR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19944-9. PubMed ID: 19036930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
    Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
    Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
    Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
    World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
    He Y; Li J; Li W; Lustigman S; Farzan M; Jiang S
    J Immunol; 2006 May; 176(10):6085-92. PubMed ID: 16670317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.
    Rockx B; Corti D; Donaldson E; Sheahan T; Stadler K; Lanzavecchia A; Baric R
    J Virol; 2008 Apr; 82(7):3220-35. PubMed ID: 18199635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.
    Howard MW; Travanty EA; Jeffers SA; Smith MK; Wennier ST; Thackray LB; Holmes KV
    J Virol; 2008 Mar; 82(6):2883-94. PubMed ID: 18199653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.